Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians-Reference-Cited by-同舟云学术

Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians

Published:2021-01-22 Issue:7 Volume:36 Page:2030-2038
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J GEN INTERN MED

Author:

Cataldi Jessica R.^ORCID,Hurley Laura P.,Lindley Megan C.,O’Leary Sean T.,Gorman Carol,Brtnikova Michaela,Beaty Brenda L.,Crane Lori A.,Shay David K.,Kempe Allison

Funder

Centers for Disease Control and Prevention

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11606-020-06397-7.pdf

Reference42 articles.

1. Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season. MMWR Recomm Rep 2018;67(3):1-20.

2. Centers for Disease Control and Prevention. Fluzone High-Dose Seasonal Influenza Vaccine. 2018; https://www.cdc.gov/flu/prevent/qa_fluzone.htm. Accessed Jun 18, 2019, 2019.

3. Lee JKH, Lam GKL, Shin T, et al. Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis. Expert Rev Vaccin 2018;17(5):435-443.

4. Izurieta HS, Thadani N, Shay DK, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 2015;15(3):293-300.

5. Richardson DM, Medvedeva EL, Roberts CB, Linkin DR, Centers for Disease C, Prevention Epicenter P. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans. Clin Infect Dis 2015;61(2):171-176.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RSAD2 Is an Effective Target for High-Yield Vaccine Production in MDCK Cells;Viruses;2022-11-21